The Market for Obesity Drugs is Growing Extremely Fast 🚀

What We’re Showing

This graphic shows the forecasted value of the global obesity drug market, based on Morgan Stanley Research estimates.

Key Takeaway

The obesity drug market is expected to grow 5x by 2030, thanks to a number of factors like:

• Introduction of new medicines (e.g. Ozempic)
• Social media promotion of weight loss results
• Expanding insurance coverage for weight loss drugs

Majority of revenue expected in the U.S.

The majority of obesity drug revenue comes from the U.S., though its share of the global total is expected to decrease throughout this decade, from 77% in 2024 to 66% in 2030.